Simcere Pharmaceutical Group Ltd (CIK 2082516) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-12). Recent activity: Sell NXTC (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | NextCure, Inc. (NXTC) | Insider | Sell | 30,000 | $184,800 |
来源：SEC Form 4 申报文件 · 截至 2026-08-12